Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Rafael Holdings Inc

(NYSE: RFL)
Add to Portfolio
-0.18 (-1.51%)
as of Apr 3, 2020

Last 11.78
Change -0.18 (-1.51%)
Open 11.74
Prev. Close 11.96
Today's Range
11.16
12.21
52wk Range
9.40
30.86
Volume 17800
Avg Volume 50010
Sector SIC-6500 Real Estate

Perfomance Comparison

Name Today 3-Month 1-Year
RFL -1.51% -47.83% -12.74%
DJIA -1.69% -27.80% -19.70%
S&P 500 -1.51% -25.17% -13.39%

Key Statistics

Annual EPS -0.41
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 189180
Weighted Alpha -30.60
Standard Deviation -0.13
Profit Margin N/A
Beta 3.08

Growth Rates

YTD -33.97%
1-Year -18.14%

Opinion

Sell Hold Buy

Recent Headlines

Rafael Holdings Reports Second Quarter Fiscal Year

PR Newswire via COMTEX - Thu Mar 05, 04:30PM EST
Rafael Holdings, Inc., (NYSE: RFL), reported revenue of $1.2 million and a loss per diluted share of $0.08 for the fiscal quarter ended January 31, 2020.(full story)
RFL: 11.78 (-0.18)

LipoMedix Announces Publication of Positive Phase 1

GlobeNewswire via COMTEX - Thu Jan 23, 09:00AM EST
LipoMedix, a clinical-stage, oncology-focused pharmaceutical company, involved in the development of innovative, safe and effective cancer therapy based on a pegylated liposomal drug delivery platform, today announced that Phase 1(full story)
RFL: 11.78 (-0.18)

Barer Institute Announces Founding Board Members

PR Newswire via COMTEX - Mon Jan 13, 05:30PM EST
The Barer Institute, a collaborative cancer drug development initiative of Rafael Holdings, Inc., (NYSE: RFL), today announced the slate of highly regarded scientific and business leaders that will serve as its founding Board of D(full story)
RFL: 11.78 (-0.18)

Rafael Holdings Launches Cancer Drug Development

PR Newswire via COMTEX - Thu Dec 19, 05:30PM EST
Rafael Holdings, Inc., (NYSE: RFL), has launched an initiative to identify and develop or in-license promising pre-clinical compounds targeting the unique cellular metabolism of cancers with high levels of unmet needs.(full story)
CE: 67.10 (-1.50), CELGZ: 0.47 (+0.01), RFL: 11.78 (-0.18)

Rafael Holdings Reports First Quarter Fiscal Year 2020

PR Newswire via COMTEX - Mon Dec 09, 04:30PM EST
Rafael Holdings, Inc., (NYSE: RFL), reported revenue of $1.2 million and a loss per share of $0.10 for the fiscal quarter ended October 31, 2019.(full story)
RFL: 11.78 (-0.18)